Patents Assigned to KAPA BIOSYSTEMS, INC.
  • Patent number: 11976275
    Abstract: The invention is a novel method of sequencing nucleic acids involving making and sequencing a library of double stranded target nucleic acids containing a linear partially single-stranded adaptor.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: May 7, 2024
    Assignees: KAPA BIOSYSTEMS, INC., ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: Aruna Arcot, Daleen Badenhorst, Jenny A. Johnson, Martin Ranik, Persis Wadia
  • Patent number: 11932847
    Abstract: Disclosed is a method of fragmenting DNA comprising contacting a sample of target DNA with (a) a composition comprising an active transpososome, and (b) a composition comprising an inactive transpososome, under conditions suitable for transpososome activity, wherein a ratio of an amount of the inactive transpososome in the composition of (b) to an amount of the active transpososome in the composition of (a) determines the mean fragment size and a level of insertion bias.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: March 19, 2024
    Assignee: KAPA BIOSYSTEMS, INC.
    Inventors: Martin Ranik, Eric Van der Walt, William Bourn, Jennifer Hsieh, Abre De Beer, Gerrida Uys, Paul McEwan
  • Patent number: 11898204
    Abstract: The invention is a novel method of separately sequencing each strand of a nucleic acid involving the use of an adaptor comprising a strand cleavage site or a strand synthesis termination site. The adaptor may also be self-priming at the strand cleavage site.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: February 13, 2024
    Assignees: Roche Sequencing Solutions, Inc., KAPA Biosystems, Inc.
    Inventors: Aruna Arcot, Daleen Badenhorst, Rui Chen, Toummy Guettouche, Ashley Hayes, Jenny A. Johnson, Severine Margeridon, Martin Ranik, Persis Wadia, Alexandra Hui Wang
  • Patent number: 11773388
    Abstract: The present disclosure provides a method for enrichment of at least one target nucleic acid in a library of nucleic acids. A first oligonucleotide is hybridized to a target nucleic acid in library of nucleic acids having first and second adapters. The hybridized first oligonucleotide is extended with a first polymerase, thereby producing a first primer extension complex including the target nucleic acid and the extended first oligonucleotide. The first primer extension complex is captured, enriched relative to the library of nucleic acids, and a second oligonucleotide is hybridized to the target nucleic acid. The hybridized second oligonucleotide is extended with a second polymerase, thereby producing a second primer extension complex including the target nucleic acid and the extended second oligonucleotide, and further liberating the extended first oligonucleotide from the first primer extension complex.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: October 3, 2023
    Assignees: Roche Sequencing Solutions, Inc., Kapa Biosystems, Inc.
    Inventors: Daniel Burgess, Brian Christopher Godwin, Alexander Lovejoy, Bronwen Miller, Jo-Anne Elizabeth Penkler, Joseph Platzer
  • Patent number: 11746339
    Abstract: The present invention provides improved DNA polymerases that may be better suited for applications in recombinant DNA technologies, in particular technologies involving plant-derived samples. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: September 5, 2023
    Assignee: Kapa Biosystems, Inc.
    Inventors: Wolfgang Schafer, Paul J. McEwan, Eric van der Walt, John Foskett, William Bourn
  • Patent number: 11603547
    Abstract: The present invention provides improved DNA polymerases, in particular, type A DNA polymerases, that may be better suited for applications in recombinant DNA technologies. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: March 14, 2023
    Assignee: Kapa Biosystems, Inc.
    Inventors: William Bourn, Maryke Appel, Gavin Rush, John Foskett, Paul J. McEwan
  • Patent number: 11427846
    Abstract: The disclosure provides a composition comprising a double-stranded deoxyribonucleic acid (dsDNA) sequence comprising from 5? to 3?, a sequence comprising a first adaptor sequence, a template sequence, and a second adaptor sequence, wherein the second adaptor sequence comprises a hybridization site for a template switching oligonucleotide (TSO). The disclosure provides methods for making the compositions of the disclosure using a template switching mechanism to add non-templated basepairs to the ends of a DNA molecule, hybridize a TSO to the non-templated basepairs, and then extend the sequence complementary to the TSO to add an adaptor.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: August 30, 2022
    Assignee: Kapa Biosystems, Inc.
    Inventors: Jennifer Hsieh, Paul McEwan, Martin Ranik, Marliz Strydom, Eric van der Walt, Ross Wadsworth
  • Patent number: 11345955
    Abstract: The invention is a novel method of making and using a library such as a sequencing library of single stranded circular nucleic acid templates via splint ligation. In particular, disclosed are methods of making circular target nucleic acid molecules and libraries of such molecules for downstream analysis such as nucleic acid sequencing. The method comprises the steps of adding universal sequences to nucleic acid molecules, rendering single-stranded these nucleic acid molecules with universal sequences on their ends by contacting with a probe complementary to at least a portion of the universal sequences, and allowing the hybridized probe to enable circularization and formation of single-stranded circular (sscDNA) molecules.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: May 31, 2022
    Assignees: ROCHE SEQUENCING SOLUTIONS, INC., KAPA BIOSYSTEMS, INC.
    Inventors: Daleen Badenhorst, Richard Dannebaum, Ashley Hayes, Monica Herrera, Severine Margeridon, Martin Ranik
  • Patent number: 11001834
    Abstract: The present invention provides synthetic nucleic acid molecule tags that can be added into samples for identification and tracking. Among other things, the present invention provides synthetic, high-molecular weight concatemers, which can be combined with samples to yield hundreds of millions of unique identifiers. Examples applications for which the synthetic nucleic acid molecule tags can be used, include industrial, research and clinical applications.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: May 11, 2021
    Assignee: KAPA BIOSYSTEMS, INC.
    Inventors: Paul McEwan, Martin Ranik, Eric van der Walt
  • Patent number: 10975361
    Abstract: The present invention provides improved DNA polymerases that may be better suited for applications in recombinant DNA technologies, in particular technologies involving plant-derived samples. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: April 13, 2021
    Assignee: Kapa Biosystems, Inc.
    Inventors: Wolfgang Schafer, Paul McEwan, Eric Van Der Walt, John Foskett, William Bourn
  • Patent number: 10961555
    Abstract: The present invention provides improved DNA polymerases, in particular, type A DNA polymerases, that may be better suited for applications in recombinant DNA technologies. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: March 30, 2021
    Assignee: Kapa Biosystems, Inc.
    Inventors: William Bourn, Maryke Appel, Gavin Rush, John Foskett, Paul J. McEwan
  • Patent number: 10907204
    Abstract: Improved methods and compositions are provided herein for primer extension target enrichment of target polynucleotides.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: February 2, 2021
    Assignees: Roche Sequencing Solutions, Inc., Kapa Biosystems, Inc.
    Inventors: Brian C. Godwin, Joseph Platzer, Janine Mok, Jo-Anne Penkler, Bronwen Miller
  • Publication number: 20200347441
    Abstract: The disclosure provides compositions and methods for high-throughput screening a plurality of transposases to identify rare mutations that affect desired features of the transposase. Compositions of the disclosures are provided that facilitate the high-throughput screening methods of the disclosure.
    Type: Application
    Filed: August 30, 2018
    Publication date: November 5, 2020
    Applicant: Kapa Biosystems, Inc.
    Inventors: Raeeza Allie, Michael Stuart Berry, William Bourn, Bjarne Faurholm, Suzanne Margaret Huddy, Martin Ranik, Du Toit Schabort
  • Patent number: 10457968
    Abstract: The present invention provides improved DNA polymerases, in particular, type A DNA polymerases, that may be better suited for applications in recombinant DNA technologies. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: October 29, 2019
    Assignee: Kapa Biosystems, Inc.
    Inventors: William Bourn, Maryke Appel, Gavin Rush, John Foskett, Paul McEwan
  • Patent number: 9388396
    Abstract: The present invention provides, among other things, chimeric DNA polymerases containing heterologous domains having sequences derived from at least two DNA polymerases that have at least one distinct functional characteristics (e.g., elongation rate, processivity, error rate or fidelity, salt tolerance or resistance) and methods of making and using the same. In some embodiments, the present invention can combine desired functional characteristics (e.g., high processivity; high elongation rate; thermostability; resistance to salt, PCR additives (e.g., PCR enhancers) and other impurities; and high fidelity) of different DNA polymerases in a chimeric polymerase.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: July 12, 2016
    Assignee: Kapa Biosystems, Inc.
    Inventors: Bjarne Faurholm, Paul McEwan, William Bourn, Gavin Rush
  • Patent number: 9315787
    Abstract: The present invention provides improved DNA polymerases that may be better suited for applications in recombinant DNA technologies, in particular technologies involving plant-derived samples. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: April 19, 2016
    Assignee: KAPA BIOSYSTEMS, INC.
    Inventors: Wolfgang Schafer, Paul McEwan, Eric Van Der Walt, John Foskett, William Bourn
  • Publication number: 20140363848
    Abstract: The present invention provides, among other things, chimeric DNA polymerases containing heterologous domains having sequences derived from at least two DNA polymerases that have at least one distinct functional characteristics (e.g., elongation rate, processivity, error rate or fidelity, salt tolerance or resistance) and methods of making and using the same. In some embodiments, the present invention can combine desired functional characteristics (e.g., high processivity; high elongation rate; thermostability; resistance to salt, PCR additives (e.g., PCR enhancers) and other impurities; and high fidelity) of different DNA polymerases in a chimeric polymerase.
    Type: Application
    Filed: May 5, 2014
    Publication date: December 11, 2014
    Applicant: KAPA BIOSYSTEMS, INC.
    Inventors: Bjarne FAURHOLM, Paul MCEWAN, William BOURN, Gavin RUSH